+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

From
Radiation Oncology - Global Strategic Business Report - Product Thumbnail Image

Radiation Oncology - Global Strategic Business Report

  • Report
  • December 2025
  • 488 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
NUT Midline Carcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

NUT Midline Carcinoma Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 383 Pages
  • Global
From
From
Bile Duct Cancer - Global Strategic Business Report - Product Thumbnail Image

Bile Duct Cancer - Global Strategic Business Report

  • Report
  • December 2025
  • 392 Pages
  • Global
From
Cancer Cachexia - Global Strategic Business Report - Product Thumbnail Image

Cancer Cachexia - Global Strategic Business Report

  • Report
  • December 2025
  • 255 Pages
  • Global
From
Cancer Registry Software - Global Strategic Business Report - Product Thumbnail Image

Cancer Registry Software - Global Strategic Business Report

  • Report
  • December 2025
  • 217 Pages
  • Global
From
Interventional Oncology Devices - Global Strategic Business Report - Product Thumbnail Image

Interventional Oncology Devices - Global Strategic Business Report

  • Report
  • December 2025
  • 282 Pages
  • Global
From
Hemato Oncology Testing - Global Strategic Business Report - Product Thumbnail Image

Hemato Oncology Testing - Global Strategic Business Report

  • Report
  • December 2025
  • 375 Pages
  • Global
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more